Literature DB >> 22298963

Barrett esophagus and life expectancy: implications for screening?

Ernst J Kuipers1.   

Abstract

Year:  2011        PMID： 22298963      PMCID： PMC3265012     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  9 in total

Review 1.  Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival?

Authors:  Evan S Dellon; Nicholas J Shaheen
Journal:  J Clin Oncol       Date:  2005-07-10       Impact factor: 44.544

2.  Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus.

Authors:  Joel H Rubenstein; Sameer D Saini; Latoya Kuhn; Laurence McMahon; Pratima Sharma; Darrell S Pardi; Philip Schoenfeld
Journal:  Am J Gastroenterol       Date:  2007-12-12       Impact factor: 10.864

3.  American Gastroenterological Association medical position statement on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

4.  Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.

Authors:  Pieter J F de Jonge; Mark van Blankenstein; Caspar W N Looman; Mariël K Casparie; Gerrit A Meijer; Ernst J Kuipers
Journal:  Gut       Date:  2010-08       Impact factor: 23.059

5.  Risk of mortality and cancer incidence in Barrett's esophagus.

Authors:  Michael B Cook; Christopher P Wild; Simon M Everett; Laura J Hardie; Kamal E Bani-Hani; Iain G Martin; David Forman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-09-21       Impact factor: 4.254

6.  Mortality rates in patients with Barrett's oesophagus.

Authors:  P Moayyedi; N Burch; N Akhtar-Danesh; S K Enaganti; R Harrison; N J Talley; J Jankowski
Journal:  Aliment Pharmacol Ther       Date:  2007-12-06       Impact factor: 8.171

7.  Management of Barrett's esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial.

Authors:  Debasish Das; Savid Ishaq; Rebecca Harrison; Kiran Kosuri; Edward Harper; John Decaestecker; Richard Sampliner; Stephen Attwood; Hugh Barr; Peter Watson; Paul Moayyedi; Janusz Jankowski
Journal:  Am J Gastroenterol       Date:  2008-04-28       Impact factor: 10.864

Review 8.  Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis.

Authors:  Marjolein Sikkema; Pieter J F de Jonge; Ewout W Steyerberg; Ernst J Kuipers
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-20       Impact factor: 11.382

9.  The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma.

Authors:  C M den Hoed; M van Blankenstein; J Dees; E J Kuipers
Journal:  Br J Cancer       Date:  2011-06-14       Impact factor: 7.640
  9 in total
  1 in total

Review 1.  Advanced Imaging for Barrett's Esophagus and Early Neoplasia: Surface and Subsurface Imaging for Diagnosis and Management.

Authors:  Mansoureh Mkarimi; Hiroshi Mashimo
Journal:  Curr Gastroenterol Rep       Date:  2018-10-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.